Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-61 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-64 |
filingDate |
1985-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b626414a9e4651289cf96f3d22f49e49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ccf92ae13646f359476ae10ca5718c |
publicationDate |
1985-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0154539-A2 |
titleOfInvention |
Recombinant DNA expression vectors and method for gene expression |
abstract |
The present invention provides a process for preparing selectable and autonomously replicating recombinant DNA expression vectors which comprise 1) a transcriptional and translational activating sequence which is in the reading frame of a nucleotide sequence that codes for a peptide or polypeptide; 2) a translational stop signal; 3) a translational start signal which is in the reading frame of a nucleotide sequence that codes for a functional polypeptide; and 4) an additional translational stop signal. The above-described nucleotide sequences are engineered to generate, upon transcription, a translatable polycistronic mRNA. The invention further provides a method of use. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5846818-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5698435-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5698417-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5693493-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6204023-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0159123-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0251842-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0379710-A1 |
priorityDate |
1984-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |